In response to the threat posed by the spread of COVID-19, CMS has called for a suspension of most state agency and accrediting organization survey activities for the indefinite future. HFAP surveys that WILL go forward include: Incoming immediate jeopardy complaints alleging infection control breaches or abuse and neglect. Complaint Surveys (lower level than immediate…
Please share this announcement with: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services Please note the CDC’s COVID-19 Information for Laboratories web page was updated on March 2, 2020. This revision includes an update to the Laboratory Biosafety Frequently Asked Questions (FAQs) to clarify practices for working inside a BSC and additional FAQs.…
Please share this announcement with: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services The Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for the CDC 2019-Novel Coronavirus (COVID-19) Real-Time RT-PCR Diagnostic Panel which is to be used in qualified laboratories for testing patient respiratory specimens that meet CDC criteria for…
Attention: Clinical Laboratories, Acute Care Hospitals, Critical Access Hospitals Please share this announcement with: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services Please note that the “Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with 2019 Novel Coronavirus (2019-nCoV)” was updated on February 10, 2020. The revisions include: The term “certified”…